Table 4.

Univariate logistic regression analysis of factors associated with outcomes

	Infections requiring hospitalizations		Death		End-stage kidney disease
	OR (95% CI)	p value	OR (95% CI)	p value	OR (95% CI)	p value
Age, years	1.03 (1–1.06)	0.08	1.03 (0.99–1.08)	0.13	1.02 (0.98–1.07)	0.28
Kidney involvement	0.55 (0.19–1.88)	0.31	–	–	–	–
PJP prophylaxis use	0.68 (0.25–1.71)	0.42	0.53 (0.14–1.72)	0.31	0.44 (0.09–1.62)	0.25
trimethoprim-sulfamethoxazole use	0.44 (0.12–1.28)	0.16	0.37 (0.06–1.15)	0.21	0.47 (0.07–1.93)	0.35
Glucocorticoid use	5.54 (2.01–15.4)	0.00	4.67 (1.36–15.71)	0.01	0.97 (0.14–4.1)	0.97
IgG level <500 mg/dL	1.86 (0.66–5.07)	0.23	0.8 (0.17–2.92)	0.76	0.92 (0.19–3.43)	0.90
CD4 count <200 cells per cubic millimeter	3.16 (0.39–20.68)	0.23	–	–	–	–
Relapsing disease	1.37 (0.52–3.47)	0.52	2.39 (0.75–7.91)	0.14	1.62 (0.44–5.72)	0.45

PJP, Pneumocystis jirovecii pneumonia.